图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

卷 24, 册 1, 2014, pp. 15-28
DOI: 10.1615/CritRevEukaryotGeneExpr.2013006875
Get accessGet access

摘要

Poly (ADP-ribose) polymerases (PARPs) are a family of related enzymes that share the ability to catalyze the transfer of ADP-ribose to target proteins. PARPs play an important role in various cellular processes, including modulation of chromatin structure, transcription, replication, recombination, and DNA repair. The role of PARP proteins in DNA repair is of particular interest, in view of the finding that certain tumors defective in homologous recombination mechanisms, may rely on PARP-mediated DNA repair for survival, and are sensitive to its inhibition. PARP inhibitors may also increase tumor sensitivity to DNA-damaging agents. Clinical trials of PARP inhibitors are investigating the utility of these approaches in cancer. The hyperactivation of PARP has also been shown to result in a specific programmed cell death pathway involving NAD+/ATP depletion, mu-calpain activation, loss of mitochondrial membrane potential, and the release of apoptosis inducing factor. Hyperactivation of the PARP pathway may be exploited to selectively kill cancer cells. Other PARP forms, including tankyrase 1 (PARP 5a), which plays an important role in enhancing telomere elongation by telomerase, have been found to be potential targets in cancer therapy. The PARP pathway and its inhibition thus offers a number of opportunities for therapeutic intervention in both cancer and other disease states.

对本文的引用
  1. Aleskandarany Mohammed, Caracappa Daniela, Nolan Christopher C., Macmillan R. Douglas, Ellis Ian O., Rakha Emad A., Green Andrew R., DNA damage response markers are differentially expressed in BRCA-mutated breast cancers, Breast Cancer Research and Treatment, 150, 1, 2015. Crossref

  2. Liu Haitao, Wang Yubin, Sharma Ashok, Mao Rui, Jiang Na, Dun Boying, She Jin-Xiong, Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling, Anti-Cancer Drugs, 26, 6, 2015. Crossref

  3. Li Zhiyuan, Zhang Liu, Li Quanshun, Induction of apoptosis in cancer cells through N-acetyl-l-leucine-modified polyethylenimine-mediated p53 gene delivery, Colloids and Surfaces B: Biointerfaces, 135, 2015. Crossref

  4. Zhang Jianxu, Wu Di, Xing Zhen, Liang Shaojun, Han Haobo, Shi Hui, Zhang Yan, Yang Yan, Li Quanshun, N-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cells, Colloids and Surfaces B: Biointerfaces, 129, 2015. Crossref

  5. Wright Roni H. G., Fernandez-Fuentes Narcis, Oliva Baldomero, Beato Miguel, Insight into the machinery that oils chromatin dynamics, Nucleus, 7, 6, 2016. Crossref

  6. Abdelali Ala`, Al-Bader Maie, Kilarkaje Narayana, Effects of Trans-Resveratrol on hyperglycemia-induced abnormal spermatogenesis, DNA damage and alterations in poly (ADP-ribose) polymerase signaling in rat testis, Toxicology and Applied Pharmacology, 311, 2016. Crossref

  7. He Qina, Sun Yulong, Zong Lin, Tong Jian, Cao Yi, Induction of Poly(ADP-ribose) Polymerase in Mouse Bone Marrow Stromal Cells Exposed to 900 MHz Radiofrequency Fields: Preliminary Observations, BioMed Research International, 2016, 2016. Crossref

  8. De Pradip, Carlson Jennifer H., Leyland-Jones Brian, Dey Nandini, PI3K-AKT-mTOR Pathway Cooperates with the DNA Damage Repair Pathway: Carcinogenesis in Triple-Negative Breast Cancers and Beyond, in PI3K-mTOR in Cancer and Cancer Therapy, 2016. Crossref

  9. Kimura Kotohiko, Huang Ru Chih C., Wu Han-Chung, Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01, PLOS ONE, 11, 2, 2016. Crossref

  10. Jubin T., Kadam A., Jariwala M., Bhatt S., Sutariya S., Gani A.R., Gautam S., Begum R., The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival, Cell Proliferation, 49, 4, 2016. Crossref

  11. Gao Rui, Li Xingyi, Xi Shaosong, Wang Haiyan, Zhang Hong, Zhu Jingling, Shan Liya, Song Xiaoming, Luo Xing, Yang Lei, Huang Jin, Exogenous Neuritin Promotes Nerve Regeneration After Acute Spinal Cord Injury in Rats, Human Gene Therapy, 27, 7, 2016. Crossref

  12. Kennedy Barry E., Sharif Tanveer, Martell Emma, Dai Cathleen, Kim Youra, Lee Patrick W.K., Gujar Shashi A., NAD+ salvage pathway in cancer metabolism and therapy, Pharmacological Research, 114, 2016. Crossref

  13. Caito Samuel W., Aschner Michael, NAD+Supplementation Attenuates Methylmercury Dopaminergic and Mitochondrial Toxicity inCaenorhabditis Elegans, Toxicological Sciences, 151, 1, 2016. Crossref

  14. Kishi Yuta, Fujihara Hisako, Kawaguchi Koji, Yamada Hiroyuki, Nakayama Ryoko, Yamamoto Nanami, Fujihara Yuko, Hamada Yoshiki, Satomura Kazuhito, Masutani Mitsuko, PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway, International Journal of Molecular Sciences, 16, 10, 2015. Crossref

  15. Ring Brian Z., Hout David R., Morris Stephan W., Lawrence Kasey, Schweitzer Brock L., Bailey Daniel B., Lehmann Brian D., Pietenpol Jennifer A., Seitz Robert S., Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients, BMC Cancer, 16, 1, 2016. Crossref

  16. Tepedelen Burcu Erbaykent, Korkmaz Mehmet, Tatlisumak Ertugrul, Uluer Elgin Türköz, Ölmez Ercüment, Değerli İsmail, Soya Elif, İnan Sevinç, A Study on the Anticarcinogenic Effects of Calcium Fructoborate, Biological Trace Element Research, 178, 2, 2017. Crossref

  17. Shen AiHua, Kim Hyung-Jin, Oh Gi-Su, Lee Su-Bin, Lee Seung Hoon, Pandit Arpana, Khadka Dipendra, Choe Seong-Kyu, Kwak Sung Chul, Yang Sei-Hoon, Cho Eun-Young, Kim Hyun-Seok, Kim Hail, Park Raekil, Kwak Tae Hwan, So Hong-Seob, NAD+ augmentation ameliorates acute pancreatitis through regulation of inflammasome signalling, Scientific Reports, 7, 1, 2017. Crossref

  18. Badawy Abdulla A-B, Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects, International Journal of Tryptophan Research, 10, 2017. Crossref

  19. Braidy Nady, Grant Ross, Kynurenine pathway metabolism and neuroinflammatory disease, Neural Regeneration Research, 12, 1, 2017. Crossref

  20. Shrivastava Neelima, Naim Mohd. Javed, Alam Md. Jahangir, Nawaz Farah, Ahmed Shujauddin, Alam Ozair, Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship, Archiv der Pharmazie, 350, 6, 2017. Crossref

  21. He Qina, Zong Lin, Sun Yulong, Vijayalaxmi , Prihoda Thomas J., Tong Jian, Cao Yi, Adaptive response in mouse bone marrow stromal cells exposed to 900 MHz radiofrequency fields: Impact of poly (ADP-ribose) polymerase (PARP), Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 820, 2017. Crossref

  22. Baptista Salete J., Silva Maria M. C., Moroni Elisabetta, Meli Massimiliano, Colombo Giorgio, Dinis Teresa C. P., Salvador Jorge A. R., Lodola Alessio, Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach, PLOS ONE, 12, 1, 2017. Crossref

  23. Macedo Giulianna Echeverria, Gomes Karen Kich, Rodrigues Nathane Rosa, Martins Illana Kemmerich, Wallau Gabriel da Luz, Carvalho Nélson Rodrigues de, Cruz Litiele Cezar da, Costa Silva Dennis Guilherme da, Boligon Aline Augusti, Franco Jeferson Luis, Posser Thaís, Senecio brasiliensis impairs eclosion rate and induces apoptotic cell death in larvae of Drosophila melanogaster, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 198, 2017. Crossref

  24. El-Sheikh Marwa M., El-Hazek Rania M., El-Khatib Aiman S., El-Ghazaly Mona A., Anti-apoptotic effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, against multiple organ damage induced by gamma irradiation in rats, International Journal of Radiation Biology, 94, 1, 2018. Crossref

  25. Vincent Mark D., Cancer: Towards a general theory of the target, BioEssays, 39, 9, 2017. Crossref

  26. Ponec Ryan M., Peddi Parvin, Callahan Rena D., PARP Inhibitors in Breast Cancer: Latest Evidence, Current Breast Cancer Reports, 9, 3, 2017. Crossref

  27. Amawi Haneen, Hussein Noor A., Karthikeyan Chandrabose, Manivannan Elangovan, Wisner Alexander, Williams Frederick E., Samuel Temesgen, Trivedi Piyush, Ashby Charles R., Tiwari Amit K., HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies, Frontiers in Pharmacology, 8, 2017. Crossref

  28. Ma Yi, He Lijie, Huang Qianwen, Zheng Shuang, Zhang Zhiqiang, Li Hongshi, Liu Shuang, Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report, BMC Medical Genetics, 19, 1, 2018. Crossref

  29. Rudolph Johannes, Mahadevan Jyothi, Dyer Pamela, Luger Karolin, Poly(ADP-ribose) polymerase 1 searches DNA via a ‘monkey bar’ mechanism, eLife, 7, 2018. Crossref

  30. Sidhu Akram, Diwan Vishal, Kaur Harsimran, Bhateja Deepak, Singh Charan K., Sharma Saurabh, Padi Satyanarayana S. V., Nicotinamide reverses behavioral impairments and provides neuroprotection in 3˗nitropropionic acid induced animal model ofHuntington’s disease: implication of oxidative stress˗ poly(ADP˗ ribose) polymerase pathway, Metabolic Brain Disease, 33, 6, 2018. Crossref

  31. Wei Xiao-Fang, Feng You-Fan, Chen Qiao-Lin, Zhang Qi-Ke, CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells, Cancer Cell International, 18, 1, 2018. Crossref

  32. Duma Narjust, Gast Kelly C., Choong Grace M., Leon-Ferre Roberto A., O’Sullivan Ciara C., Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?, Current Oncology Reports, 20, 8, 2018. Crossref

  33. Caffo Orazio, Veccia Antonello, Kinspergher Stefania, Rizzo Mimma, Maines Francesca, Aberrations of DNA Repair Pathways in Prostate Cancer: Future Implications for Clinical Practice?, Frontiers in Cell and Developmental Biology, 6, 2018. Crossref

  34. Cramer Tomer, Rosenberg Tali, Kisliouk Tatiana, Meiri Noam, PARP Inhibitor Affects Long-term Heat-stress Response via Changes in DNA Methylation, Neuroscience, 399, 2019. Crossref

  35. Chagoya de Sánchez Victoria, Chávez Enrique, Velasco- Loyden Gabriela, Guadalupe Lozano-Rosas María, Rusbel Aparicio-Cadena Alejandro, Interaction of Mitochondrial and Epigenetic Regulation in Hepatocellular Carcinoma, in Liver Cancer, 2018. Crossref

  36. Fountzilas Christos, Kaklamani Virginia G., Multi-gene Panel Testing in Breast Cancer Management, in Optimizing Breast Cancer Management, 173, 2018. Crossref

  37. Cimmino Luisa, Neel Benjamin G., Aifantis Iannis, Vitamin C in Stem Cell Reprogramming and Cancer, Trends in Cell Biology, 28, 9, 2018. Crossref

  38. Mikuła-Pietrasik Justyna, Witucka Anna, Pakuła Martyna, Uruski Paweł, Begier-Krasińska Beata, Niklas Arkadiusz, Tykarski Andrzej, Książek Krzysztof, Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells, Cellular and Molecular Life Sciences, 76, 4, 2019. Crossref

  39. Johnson Sean, Imai Shin–ichiro, NAD+ biosynthesis, aging, and disease, F1000Research, 7, 2018. Crossref

  40. Pan Haibo, Wang Fang, Rankin Gary O., Rojanasakul Yon, Tu Youying, Chen Yi Charlie, Inhibitory effect of black tea pigments, theaflavin-3/3′-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest, International Journal of Oncology, 51, 5, 2017. Crossref

  41. Abbehausen C., Zinc finger domains as therapeutic targets for metal-based compounds – an update, Metallomics, 11, 1, 2019. Crossref

  42. Park Bong-Soo, Kil Jong-Jin, Kang Hae-Mi, Yu Su-Bin, Park Dan-Bi, Park Jin-A, Kim In-Ryoung, Luteolin Induces Apoptosis via Mitochondrial Pathway and Inhibits Invasion and Migration of Oral Squamous Cell Carcinoma by Suppressing Epithelial-Mesenchymal Transition Induced Transcription Factors, International Journal of Oral Biology, 43, 2, 2018. Crossref

  43. Singh Reema, Chaudhary Priyanka, Arya Ranjana, Role of IGF-1R in ameliorating apoptosis of GNE deficient cells, Scientific Reports, 8, 1, 2018. Crossref

  44. Demiroglu-Zergeroglu Asuman, Ayvali Nurettin, Turhal Gulseren, Ceylan Hurmuz, Nacak Baytas Sultan, Investigation of potent anticarcinogenic activity of 1, 3-diarylpyrazole acrylamide derivatives in vitro , Journal of Pharmacy and Pharmacology, 70, 12, 2018. Crossref

  45. Tlemsani Camille, Pasmant Eric, Boudou-Rouquette Pascaline, Bellesoeur Audrey, Even Julien, Larousserie Frédérique, Reyes Cécile, Gentien David, Alexandre Jérôme, Vidaud Michel, Anract Philippe, Leroy Karen, Goldwasser François, BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic Medicine, The American Journal of the Medical Sciences, 356, 4, 2018. Crossref

  46. Pajuelo David, Gonzalez-Juarbe Norberto, Tak Uday, Sun Jim, Orihuela Carlos J., Niederweis Michael, NAD+ Depletion Triggers Macrophage Necroptosis, a Cell Death Pathway Exploited by Mycobacterium tuberculosis, Cell Reports, 24, 2, 2018. Crossref

  47. Aman Yahyah, Qiu Yumin, Tao Jun, Fang Evandro F., Therapeutic potential of boosting NAD+ in aging and age-related diseases, Translational Medicine of Aging, 2, 2018. Crossref

  48. Elamin Marwa, Ruskin David N., Masino Susan A., Sacchetti Paola, Ketogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus, Frontiers in Cellular Neuroscience, 12, 2018. Crossref

  49. Palanissami Gowri, Paul Solomon F. D., RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review, Hormones and Cancer, 9, 5, 2018. Crossref

  50. Abdel-Magied Nadia, Shedid Shereen M., Ahmed Amal G., Mitigating effect of biotin against irradiation-induced cerebral cortical and hippocampal damage in the rat brain tissue, Environmental Science and Pollution Research, 26, 13, 2019. Crossref

  51. Leszczynska Katarzyna B., Temper Nadya, Bristow Robert G., Hammond Ester M., Targeting Tumour Hypoxia with PARP Inhibitors: Contextual Synthetic Lethality, in PARP Inhibitors for Cancer Therapy, 83, 2015. Crossref

  52. Chei Sungwoo, Oh Hyun-Ji, Song Ji-Hyeon, Seo Young-Jin, Lee Kippeum, Lee Boo-Yong, Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells, Frontiers in Oncology, 9, 2019. Crossref

  53. Kim Hyung‐Jin, Cao Wa, Oh Gi‐Su, Lee SeungHoon, Shen AiHua, Khadka Dipendra, Lee Su‐Bin, Sharma Subham, Kim Seon Young, Choe Seong‐Kyu, Kwak Tae Hwan, Kim Jin‐Man, Park Raekil, So Hong‐Seob, Augmentation of cellular NAD + by NQO1 enzymatic action improves age‐related hearing impairment , Aging Cell, 18, 5, 2019. Crossref

  54. Natali Federica, Rancati Giulia, The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology, Frontiers in Genetics, 10, 2019. Crossref

  55. Feng Yanling, Huang He, Wan Ting, Zhang Chuyao, Tong Chongjie, Liu Jihong, Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis, Advances in Therapy, 36, 12, 2019. Crossref

  56. Thi-Kim Nguyen , Moon , Ryu , Eum , Bach , Cho , Methanol Extract of Aerial Parts of Pavetta indica L. Enhances the Cytotoxic Effect of Doxorubicin and Induces Radiation Sensitization in MDA-MB-231 Triple-Negative Breast Cancer Cells, Molecules, 24, 12, 2019. Crossref

  57. Xu Xiaoxiao, Guo Chao, Liang Xiaoliu, Li Rong, Chen Jian, Potential biomarker of fibroblast growth factor 21 in valproic acid‐treated livers, BioFactors, 45, 5, 2019. Crossref

  58. Lombard Alan P, Liu Chengfei, Armstrong Cameron M, D'Abronzo Leandro S, Lou Wei, Chen Hongwu, Dall'Era Marc, Ghosh Paramita M, Evans Christopher P, Gao Allen C, Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer, Translational Oncology, 12, 7, 2019. Crossref

  59. Francisco Ana P., Mendes Eduarda, Santos Ana R., Perry Maria J., Anticancer Triazenes: from Bioprecursors to Hybrid Molecules, Current Pharmaceutical Design, 25, 14, 2019. Crossref

  60. Chantarasriwong Oraphin, Dorwart Tanis J., Morales Theodore Habarth, Maggio Stephanie F., Settle Aspen L., Milcarek Andrew T., Alpaugh Mary L., Theodoraki Maria A., Theodorakis Emmanuel A., Chiral resolution of a caged xanthone and evaluation across a broad spectrum of breast cancer subtypes, Bioorganic Chemistry, 93, 2019. Crossref

  61. Fujihara Hisako, Nozaki Tadashige, Tsutsumi Masahiro, Isumi Mayu, Shimoda Shinji, Hamada Yoshiki, Masutani Mitsuko, Spontaneous Development of Dental Dysplasia in Aged Parp-1 Knockout Mice, Cells, 8, 10, 2019. Crossref

  62. Lai Kuang-Chi, Chueh Fu-Shin, Hsiao Yung-Ting, Cheng Zheng-Yu, Lien Jin-Cherng, Liu Kuo-Ching, Peng Shu-Fen, Chung Jing-Gung, Gefitinib and curcumin-loaded nanoparticles enhance cell apoptosis in human oral cancer SAS cells in vitro and inhibit SAS cell xenografted tumor in vivo, Toxicology and Applied Pharmacology, 382, 2019. Crossref

  63. Mahadevan Jyothi, Rudolph Johannes, Jha Asmita, Tay Jian Wei, Dragavon Joseph, Grumstrup Erik M., Luger Karolin, Q-FADD: A Mechanistic Approach for Modeling the Accumulation of Proteins at Sites of DNA Damage, Biophysical Journal, 116, 11, 2019. Crossref

  64. Li Chenguang, Zhang Jie, Xue Mei, Li Xiaoyu, Han Fei, Liu Xiangyang, Xu Linxin, Lu Yunhong, Cheng Ying, Li Ting, Yu Xiaochen, Sun Bei, Chen Liming, SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart, Cardiovascular Diabetology, 18, 1, 2019. Crossref

  65. Kulkarni Chaitanya A., Brookes Paul S., Cellular Compartmentation and the Redox/Nonredox Functions of NAD+, Antioxidants & Redox Signaling, 31, 9, 2019. Crossref

  66. Badawy Abdulla Abu-Bakr, Tryptophan Metabolism: A Versatile Area Providing Multiple Targets for Pharmacological Intervention, Egyptian Journal of Basic and Clinical Pharmacology, 9, 2019. Crossref

  67. Wen Deng-Tai, Zheng Lan, Li Jin-xiu, Cheng Dan, Liu Yang, Lu Kai, Hou Wen-qi, Endurance exercise resistance to lipotoxic cardiomyopathy is associated with cardiac NAD+/dSIR2/PGC-1α pathway activation in old Drosophila , Biology Open, 8, 10, 2019. Crossref

  68. Moore Kathleen, Chan John K., Secord Angeles Alvarez, Patel Manish R., Callahan Timothy, Guo Wei, Zhang Zhi-Yi, Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, Cancer Chemotherapy and Pharmacology, 83, 4, 2019. Crossref

  69. Sambi Manpreet, Qorri Bessi, Harless William, Szewczuk Myron R., Therapeutic Options for Metastatic Breast Cancer, in Breast Cancer Metastasis and Drug Resistance, 1152, 2019. Crossref

  70. Baloch Tahira, López-Ozuna Vanessa M., Wang Qiong, Matanis Emad, Kessous Roy, Kogan Liron, Yasmeen Amber, Gotlieb Walter H., Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1, BMC Cancer, 19, 1, 2019. Crossref

  71. Huang Chun-Hao, Lei Kin Fong, Tsang Ngan-Ming, Apoptosis and cell cycle arrest of hepatocellular carcinoma spheroids treated by an alternating electric field, Biotechnology Progress, 35, 3, 2019. Crossref

  72. Pondé Noam, Wildiers Hans, Awada Ahmad, de Azambuja Evandro, Deliens Coralie, Lago Lissandra Dal, Targeted therapy for breast cancer in older patients, Journal of Geriatric Oncology, 11, 3, 2020. Crossref

  73. Guney Eskiler Gamze, Cecener Gulsah, Egeli Unal, Tunca Berrin, BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile, Journal of Biochemical and Molecular Toxicology, 33, 5, 2019. Crossref

  74. Pearson Scott J., Elswood Jessica, Barhoumi Rola, Ming-Whitfield Brittini, Rijnkels Monique, Porter Weston W., Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress, Breast Cancer Research, 21, 1, 2019. Crossref

  75. Rudolph Johannes, Luger Karolin, Kinetics of DNA–protein association and dissociation by stopped-flow spectroscopy, in DNA Sensors and Inflammasomes, 625, 2019. Crossref

  76. Gubina-Vakulyck Galina, Gorbach Tatiana, Onishchenko Anatolii, Novikova Viktoriia, Nakonechna Oksana, Tryfonova Nataliia, Butova Tetiana, Tkachenko Anton, Apoptosis and regeneration of hepatocytes in rats orally exposed to caffeinated energy drinks, Comparative Clinical Pathology, 29, 2, 2020. Crossref

  77. Erdogan Suat, Turkekul Kader, Dibirdik Ilker, Doganlar Zeynep B., Doganlar Oguzhan, Bilir Ayhan, Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB, Investigational New Drugs, 38, 2, 2020. Crossref

  78. Mitra Anindita, Biswas Ria, Bagchi Angshuman, Ghosh Rita, Insight into the binding of a synthetic nitro-flavone derivative with human poly (ADP-ribose) polymerase 1, International Journal of Biological Macromolecules, 141, 2019. Crossref

  79. Prawira Aldo, Munusamy Prabhakaran, Yuan Jimin, Chan Claire Hian Tzer, Koh Geok Ling, Shuen Timothy Wai Ho, Hu Jiancheng, Yap Yoon Sim, Tan Min Han, Ang Peter, Lee Ann Siew Gek, Assessment of PARP4 as a candidate breast cancer susceptibility gene, Breast Cancer Research and Treatment, 177, 1, 2019. Crossref

  80. Bergamaschi D., Vossenkamper A., Lee W. Y. J., Wang P., Bochukova E., Warnes G., Simultaneous polychromatic flow cytometric detection of multiple forms of regulated cell death, Apoptosis, 24, 5-6, 2019. Crossref

  81. da Silva Júnior Eufrânio N., Jardim Guilherme A.M., Jacob Claus, Dhawa Uttam, Ackermann Lutz, de Castro Solange L., Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones, European Journal of Medicinal Chemistry, 179, 2019. Crossref

  82. Goud Nerella Sridhar, Joshi Raman Kumar, Bharath Rose Dawn, Kumar Pardeep, Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis, European Journal of Medicinal Chemistry, 187, 2020. Crossref

  83. Kaiser Thomas M., Burger Pieter B., Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets, Molecules, 24, 11, 2019. Crossref

  84. Damale Manoj G., Patil Rajesh, Ansari Siddique Akber, Alkahtani Hamad M., Almehizia Abdulrahman A., Pathan Shahebaaz K., Chhajed Santosh, Sangshetti Jaiprakash, Identification of dual site inhibitors of tankyrase through virtual screening of protein-ligand interaction fingerprint (PLIF)–derived pharmacophore models, molecular dynamics, and ADMET studies, Structural Chemistry, 31, 2, 2020. Crossref

  85. Tsika Aikaterini C., Melekis Efstathios, Tsatsouli Sofia-Antigoni, Papageorgiou Nicolas, Maté Maria J., Canard Bruno, Coutard Bruno, Bentrop Detlef, Spyroulias Georgios A., Deciphering the Nucleotide and RNA Binding Selectivity of the Mayaro Virus Macro Domain, Journal of Molecular Biology, 431, 12, 2019. Crossref

  86. Park Kwang-Ha, Choi Jeong-Hae, Song Yeon-Suk, Kim Gyoo-Cheon, Hong Jin-Woo, Ethanol extract of asiasari radix preferentially induces apoptosis in G361 human melanoma cells by differential regulation of p53, BMC Complementary and Alternative Medicine, 19, 1, 2019. Crossref

  87. Sharifi-Rad Javad, Ozleyen Adem, Boyunegmez Tumer Tugba, Oluwaseun Adetunji Charles, El Omari Nasreddine, Balahbib Abdelaali, Taheri Yasaman, Bouyahya Abdelhakim, Martorell Miquel, Martins Natália, C. Cho William, Natural Products and Synthetic Analogs as a Source of Antitumor Drugs, Biomolecules, 9, 11, 2019. Crossref

  88. Aktas Burak Yasin, Guner Gurkan, Guven Deniz Can, Arslan Cagatay, Dizdar Omer, Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy, Expert Review of Anticancer Therapy, 19, 7, 2019. Crossref

  89. Vossenkamper Anna, Warnes Gary, Flow Cytometry Reveals the Nature of Oncotic Cells, International Journal of Molecular Sciences, 20, 18, 2019. Crossref

  90. George Blassan P., Abrahamse Heidi, Increased Oxidative Stress Induced by Rubus Bioactive Compounds Induce Apoptotic Cell Death in Human Breast Cancer Cells, Oxidative Medicine and Cellular Longevity, 2019, 2019. Crossref

  91. Krishnan Muthaiah Vijaya Prakash, Palaniappan Tamilselvi, Rajan Sridhar Skylab, Chandrasekar Kirubhanand, Venkatachalam Sankar, Attenuation of oxidative stress after contusion spinal cord injury through inhibition of Poly ADP Ribose Polymerase involves glutamate cysteine ligase, Process Biochemistry, 84, 2019. Crossref

  92. Singh Naveen, Pay S. Louise, Bhandare Snehal B., Arimpur Udhaya, Motea Edward A., Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy, Cancers, 12, 4, 2020. Crossref

  93. Peters Xylia Q., Malinga Thembeka H., Agoni Clement, Olotu Fisayo A., Soliman Mahmoud E.S., Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies, Anti-Cancer Agents in Medicinal Chemistry, 19, 16, 2020. Crossref

  94. Shmulevich Riva, Krizhanovsky Valery, Cell Senescence, DNA Damage, and Metabolism, Antioxidants & Redox Signaling, 34, 4, 2021. Crossref

  95. Chinopoulos Christos, Acute sources of mitochondrial NAD+ during respiratory chain dysfunction, Experimental Neurology, 327, 2020. Crossref

  96. Hughes C H K, Inskeep E K, Pate J L, Temporal changes in the corpus luteum during early pregnancy reveal regulation of pathways that enhance steroidogenesis and suppress luteolytic mechanisms†, Biology of Reproduction, 103, 1, 2020. Crossref

  97. Demétrio de Souza França Paula, Roberts Sheryl, Kossatz Susanne, Guru Navjot, Mason Christian, Zanoni Daniella Karassawa, Abrahão Marcio, Schöder Heiko, Ganly Ian, Patel Snehal G., Reiner Thomas, Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging, Nuclear Medicine and Biology, 84-85, 2020. Crossref

  98. Lisi Lucia, Chiavari Marta, Ciotti Gabriella Maria Pia, Lacal Pedro M., Navarra Pierluigi, Graziani Grazia, DNA inhibitors for the treatment of brain tumors, Expert Opinion on Drug Metabolism & Toxicology, 16, 3, 2020. Crossref

  99. Chen Yangzong, Bao Chunchun, Zhang Xiuxing, Lin Xinshi, Fu Yimou, Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma, Cancer Cell International, 20, 1, 2020. Crossref

  100. Chen Yi‐Ching, Chen Pei‐Ni, Lin Chiao‐Wen, Yang Wei‐En, Ho Yu‐Ting, Yang Shun‐Fa, Chuang Chun‐Yi, Cantharidic acid induces apoptosis in human nasopharyngeal carcinoma cells through p38‐mediated upregulation of caspase activation, Environmental Toxicology, 35, 5, 2020. Crossref

  101. Keung Man Yee, Wu Yanyuan, Badar Francesca, Vadgama Jaydutt V., Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status, Journal of Clinical Medicine, 9, 4, 2020. Crossref

  102. Ren Ning, Chen Lianfu, Li Bo, Rankin Gary O., Chen Yi Charlie, Tu Youying, Purified Tea (Camellia sinensis (L.) Kuntze) Flower Saponins Induce the p53-Dependent Intrinsic Apoptosis of Cisplatin-Resistant Ovarian Cancer Cells, International Journal of Molecular Sciences, 21, 12, 2020. Crossref

  103. Patel Mausam, Nowsheen Somaira, Maraboyina Sanjay, Xia Fen, The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review, Cell & Bioscience, 10, 1, 2020. Crossref

  104. Ruff Michael, Kizilbash Sani, Buckner Jan, Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development, Expert Review of Anticancer Therapy, 20, 5, 2020. Crossref

  105. Vodicka Pavel, Urbanova Marketa, Makovicky Pavol, Tomasova Kristyna, Kroupa Michal, Stetina Rudolf, Opattova Alena, Kostovcikova Klara, Siskova Anna, Schneiderova Michaela, Vymetalkova Veronika, Vodickova Ludmila, Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients, International Journal of Molecular Sciences, 21, 7, 2020. Crossref

  106. Aðalsteinsson Heiðar Mar, Lima Frederico A., Galuppo Carolina, Abbehausen Camilla, Evaluation of cobalt complexes with tripod ligands for zinc finger targeting, Dalton Transactions, 49, 45, 2020. Crossref

  107. Rebhan Katharina, Laukhtina Ekaterina, Shariat Shahrokh F., Gust Kilian M., Frontiers in combining immune checkpoint inhibitors for advanced urothelial cancer management, Current Opinion in Urology, 30, 3, 2020. Crossref

  108. Kaczor-Keller Katarzyna B., Pawlik Anna, Scianowski Jacek, Pacuła Agata, Obieziurska Magdalena, Marcheggiani Fabio, Cirilli Ilenia, Tiano Luca, Antosiewicz Jedrzej, In Vitro Anti-Prostate Cancer Activity of Two Ebselen Analogues, Pharmaceuticals, 13, 3, 2020. Crossref

  109. Tang Linsong, Chen Ronggao, Xu Xiao, Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma, Cancer Letters, 476, 2020. Crossref

  110. Liang Yujia, Zhou Rui, Liang Xiaoliu, Kong Xiaolong, Yang Bin, Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study, European Journal of Pharmacology, 881, 2020. Crossref

  111. Gorini Francesca, Scala Giovanni, Di Palo Giacomo, Dellino Gaetano Ivan, Cocozza Sergio, Pelicci Pier Giuseppe, Lania Luigi, Majello Barbara, Amente Stefano, The genomic landscape of 8-oxodG reveals enrichment at specific inherently fragile promoters, Nucleic Acids Research, 48, 8, 2020. Crossref

  112. Ferreira Hugo Jefferson, de Almeida Evandro Moreira, da Silva Wildson Max Barbosa, Teixeira Edson Holanda, do Nascimento Neto Luiz Gonzaga, Molecular Mechanisms Involved in the Antitumor Activity of Isolated Lectins from Marine Organisms: A Systematic Review, Current Drug Targets, 21, 6, 2020. Crossref

  113. Lastra Ruben O., Paunesku Tatjana, Gutama Barite, Reyes Filiberto, François Josie, Martinez Shelby, Xin Lun, Brown Koshonna, Zander Alia, Raha Sumita, Protic Miroslava, Nanavati Dhaval, Bi Yingtao, Woloschak Gayle E, Protein Binding Effects of Dopamine Coated Titanium Dioxide Shell Nanoparticles, Precision Nanomedicine, 2, 4, 2019. Crossref

  114. Elleuch Fatma, Baril Patrick, Barkallah Mohamed, Perche Federico, Abdelkafi Slim, Fendri Imen, Pichon Chantal, Deciphering the Biological Activities of Dunaliella sp. Aqueous Extract from Stressed Conditions on Breast Cancer: from in Vitro to in Vivo Investigations, International Journal of Molecular Sciences, 21, 5, 2020. Crossref

  115. Ünlü Ayhan, Dinç Bircan, Investigation of the three-dimensional structure and interaction mechanism of poly (ADP-ribose) polymerase 4, Biotechnology & Biotechnological Equipment, 34, 1, 2020. Crossref

  116. Nunes Higor Lopes, Tuttis Katiuska, Serpeloni Juliana Mara, Nascimento Jessyane Rodrigues do, da Rocha Claudia Quintino, Silva Viviane Aline Oliveira, Lengert André van Helvoort, Reis Rui Manuel, de Syllos Cólus Ilce Mara, Characterization of the in vitro cytotoxic effects of brachydins isolated from Fridericia platyphylla in a prostate cancer cell line, Journal of Toxicology and Environmental Health, Part A, 83, 15-16, 2020. Crossref

  117. Jang Albert, Sartor Oliver, Barata Pedro C., Paller Channing J., Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer, Cancers, 12, 11, 2020. Crossref

  118. Eldin A. Osman Essam, Hanafy Noura S., George Riham F., El-Moghazy Samir M., Design and synthesis of some barbituric and 1,3-dimethylbarbituric acid derivatives: A non-classical scaffold for potential PARP1 inhibitors, Bioorganic Chemistry, 104, 2020. Crossref

  119. Khan Andleeb, Alshahrani Saeed, Arafah Azher, Qamar Wajhul, Shoaib Ambreen, Wali Adil Farooq, Amin Insha, Alqahtani Saad Saeed, Rehman Muneeb U., Possible Therapeutic Potential of Flavonoids and Phenolic Acids from Honey in Age-Related Neurodegenerative Diseases Via Targeting NAD+ Degradation, in Therapeutic Applications of Honey and its Phytochemicals, 2020. Crossref

  120. Dash Sabyasachi, Balasubramaniam Muthukumar, Martínez-Rivera Freddyson J., Godino Arthur, Peck Emily G., Patnaik Srinivas, Suar Mrutyunjay, Calipari Erin S., Nestler Eric J., Villalta Fernando, Dash Chandravanu, Pandhare Jui, Cocaine-regulated microRNA miR-124 controls poly (ADP-ribose) polymerase-1 expression in neuronal cells, Scientific Reports, 10, 1, 2020. Crossref

  121. Zhang Zhimin, Chang Xinyue, Zhang Chixiao, Zeng Shenxin, Liang Meihao, Ma Zhen, Wang Zunyuan, Huang Wenhai, Shen Zhengrong, Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1), Journal of Enzyme Inhibition and Medicinal Chemistry, 35, 1, 2020. Crossref

  122. Wang Xiaobo, Wu Tengteng, Zhang Jinru, Guo Gongbo, He XiaoFei, Pei Zhong, Liu Zhaohui, Liu Chun-feng, Ross Christopher A., Smith Wanli W., Transmembrane Protein 230 Mediates a Poly(ADP-ribose) Polymerase-1-Linked Apoptosis, Frontiers in Aging Neuroscience, 12, 2020. Crossref

  123. Shah Jay V., Gonda Amber, Pemmaraju Rahul, Subash Aishwarya, Bobadilla Mendez Carolina, Berger Marissa, Zhao Xinyu, He Shuqing, Riman Richard E., Tan Mei Chee, Pierce Mark C., Moghe Prabhas V., Ganapathy Vidya, Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring, Frontiers in Molecular Biosciences, 7, 2020. Crossref

  124. Ismail Nor Isnida, Othman Iekhsan, Abas Faridah, H. Lajis Nordin, Naidu Rakesh, The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells, Molecules, 25, 17, 2020. Crossref

  125. Starcher Colton L., Pay S. Louise, Singh Naveen, Yeh I-Ju, Bhandare Snehal B., Su Xiaolin, Huang Xiumei, Bey Erik A., Motea Edward A., Boothman David A., Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer, Frontiers in Oncology, 10, 2020. Crossref

  126. Lakshmanan Kaviarasan, Byran Gowramma, Mohammed Manal, A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception, Current Enzyme Inhibition, 16, 2, 2020. Crossref

  127. GUNDOGDU Ramazan, Inhibition of Colorectal Cancer Cell Survival by Paclitaxel Combined with Olaparib, Adıyaman University Journal of Science, 2020. Crossref

  128. Liu Xia , Peng Jiamin , Zhou Yayun , Xie Bei , Wang Jianchao , Silencing RRM2 inhibits multiple myeloma by�targeting the Wnt/β‑catenin signaling pathway, Molecular Medicine Reports, 2019. Crossref

  129. Roychowdhury Tanaya, Chattopadhyay Samit, Chemical Decorations of “MARs” Residents in Orchestrating Eukaryotic Gene Regulation, Frontiers in Cell and Developmental Biology, 8, 2020. Crossref

  130. Jung Ji Hoon, Lee Hyo-Jung, Kim Ju-Ha, Sim Deok Yong, Im Eunji, Kim Sinae, Chang Suhwan, Kim Sung-Hoon, Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2, Cells, 9, 4, 2020. Crossref

  131. Kaya-Dagistanli Fatma, Ozturk Melek, Transdifferentiation of both intra- and extra-islet cells into beta cells in nicotinamide treated neonatal diabetic rats: An in situ hybridization and double immunohistochemical study, Acta Histochemica, 122, 7, 2020. Crossref

  132. Tsakali Sofia Serena, Shanahan Catherine M., Calcinosis: insights from other calcinoses, Current Opinion in Rheumatology, 32, 6, 2020. Crossref

  133. Carullo Gabriele, Mazzotta Sarah, Koch Adrian, Hartmann Kristin M., Friedrich Oliver, Gilbert Daniel F., Vega-Holm Margarita, Schneider-Stock Regine, Aiello Francesca, New Oleoyl Hybrids of Natural Antioxidants: Synthesis and In Vitro Evaluation as Inducers of Apoptosis in Colorectal Cancer Cells, Antioxidants, 9, 11, 2020. Crossref

  134. Doroftei Bogdan, Ilie Ovidiu-Dumitru, Cojocariu Roxana-Oana, Ciobica Alin, Maftei Radu, Grab Delia, Anton Emil, McKenna Jack, Dhunna Nitasha, Simionescu Gabriela, Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects, Molecules, 25, 15, 2020. Crossref

  135. Wu Ji-Heng, Cao Yue-Ting, Pan Hong-Ye, Wang Long-Hu, Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism, Molecules, 25, 18, 2020. Crossref

  136. Sobczak Maciej, Zyma Marharyta, Robaszkiewicz Agnieszka, The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors, Cells, 9, 9, 2020. Crossref

  137. Badawy Abdulla A.-B., Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide, Bioscience Reports, 40, 10, 2020. Crossref

  138. Singh Bijay, Yang Shicheng, Krishna Apurva, Sridhar Srinivas, Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy, Frontiers in Chemistry, 8, 2020. Crossref

  139. Varanda Ana Beatriz, Martins-Logrado Ana, Godinho Ferreira Miguel, Fior Rita, Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status, Cancers, 12, 7, 2020. Crossref

  140. Ali Mahmoud A., Abu Damir Hassan, Ali Osman M., Amir Naheed, Tariq Saeed, Greenwood Michael P., Lin Panjiao, Gillard Benjamin, Murphy David, Adem Abdu, The effect of long-term dehydration and subsequent rehydration on markers of inflammation, oxidative stress and apoptosis in the camel kidney, BMC Veterinary Research, 16, 1, 2020. Crossref

  141. Sitarek Przemysław, Merecz-Sadowska Anna, Śliwiński Tomasz, Zajdel Radosław, Kowalczyk Tomasz, An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines, Cancers, 12, 10, 2020. Crossref

  142. Amirkhani Namagerdi Asadoor, d’Angelo Danila, Ciani Francesca, Iannuzzi Carmelina Antonella, Napolitano Francesco, Avallone Luigi, De Laurentiis Michelino, Giordano Antonio, Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology, Frontiers in Oncology, 10, 2020. Crossref

  143. Li Jie, Li Xiang, Yuan Yan, Wang Qi, Xie Lisi, Dai Yunlu, Wang Wenjun, Li Lin, Lu Xiaomei, Fan Quli, Huang Wei, Efficient Polysulfide‐Based Nanotheranostics for Triple‐Negative Breast Cancer: Ratiometric Photoacoustics Monitored Tumor Microenvironment‐Initiated H 2 S Therapy , Small, 16, 39, 2020. Crossref

  144. Narota Arun, Kumar Sandeep, Kaur Rhythmjot, Kaur Sachdeep, Aggarwal Ritu, Agnihotri Navneet, Althea rosea seed extract ameliorates 1,2-dimethylhydrazine induced preneoplastic lesions in mouse model of colon cancer by modulating oxidative stress and inflammation, Pharmacognosy Magazine, 16, 70, 2020. Crossref

  145. Rahimian Elahe, Amini Ali, Alikarami Fatemeh, Pezeshki Seyed Mohammad Sadegh, Saki Najmaldin, Safa Majid, DNA repair pathways as guardians of the genome: Therapeutic potential and possible prognostic role in hematologic neoplasms, DNA Repair, 96, 2020. Crossref

  146. Covarrubias Anthony J., Perrone Rosalba, Grozio Alessia, Verdin Eric, NAD+ metabolism and its roles in cellular processes during ageing, Nature Reviews Molecular Cell Biology, 22, 2, 2021. Crossref

  147. Lal Samridhi, Snape Timothy J., A therapeutic update on PARP inhibitors: implications in the treatment of glioma, Drug Discovery Today, 26, 2, 2021. Crossref

  148. Kar Anwesha, Mehrotra Shikhar, Chatterjee Shilpak, CD38: T Cell Immuno-Metabolic Modulator, Cells, 9, 7, 2020. Crossref

  149. Hamilton Kelly L., Sheehan Stephanie A., Retzbach Edward P., Timmerman Clinton A., Gianneschi Garret B., Tempera Patrick J., Balachandran Premalatha, Goldberg Gary S., Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways, Journal of Cancer Research and Clinical Oncology, 147, 2, 2021. Crossref

  150. Dallavalle Sabrina, Princiotto Salvatore, Mattio Luce M., Artali Roberto, Musso Loana, Aviñó Anna, Eritja Ramon, Pisano Claudio, Gargallo Raimundo, Mazzini Stefania, Investigation of the Complexes Formed between PARP1 Inhibitors and PARP1 G-Quadruplex at the Gene Promoter Region, International Journal of Molecular Sciences, 22, 16, 2021. Crossref

  151. Zhao Fengjiao, Zhou Yong, Seesaha Poshita Kumari, Zhang Yihong, Liu Siqin, Gan Xiaoyan, Hu Jun, Gu Yanhong, Chen Xiaofeng, Olaparib combined with immunotherapy for treating a patient with liver cancer carrying BRCA2 germline mutation, Medicine, 99, 38, 2020. Crossref

  152. Hia Fabian, Takeuchi Osamu, The Role of Ribonucleases in RNA Damage, Inactivation and Degradation, in RNA Damage and Repair, 2021. Crossref

  153. Perrone Maria Grazia, Luisi Oreste, De Grassi Anna, Ferorelli Savina, Cormio Gennaro, Scilimati Antonio, Translational Theragnosis of Ovarian Cancer: where do we stand?, Current Medicinal Chemistry, 27, 34, 2020. Crossref

  154. Mavian Carla, Ramirez-Mata Andrea S., Dollar James Jarad, Nolan David J., Cash Melanie, White Kevin, Rich Shannan N., Magalis Brittany Rife, Marini Simone, Prosperi Mattia C. F., Amador David Moraga, Riva Alberto, Williams Kenneth C., Salemi Marco, Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeutic targets, Journal of NeuroVirology, 27, 1, 2021. Crossref

  155. Lee Dahae, Ko Hyeonseok, Kim Young-Joo, Kim Su-Nam, Choi Kyung-Chul, Yamabe Noriko, Kim Ki Hyun, Kang Ki Sung, Kim Hyun Young, Shibamoto Takayuki, Inhibition of A2780 Human Ovarian Carcinoma Cell Proliferation by a Rubus Component, Sanguiin H-6, Journal of Agricultural and Food Chemistry, 64, 4, 2016. Crossref

  156. Jonuscheit Stephanie, Jost Tina, Gajdošová Fritzi, Wrobel Maximilian, Hecht Markus, Fietkau Rainer, Distel Luitpold, PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation, Genes, 12, 6, 2021. Crossref

  157. Liposits Gabor, Loh Kah Poh, Soto-Perez-de-Celis Enrique, Dumas Lucy, Battisti Nicolò Matteo Luca, Kadambi Sindhuja, Baldini Capucine, Banerjee Susana, Lichtman Stuart M., PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper, Journal of Geriatric Oncology, 10, 2, 2019. Crossref

  158. Mentoor Ilze, Engelbrecht Anna-Mart, van de Vyver Mari, van Jaarsveld Paul J., Nell Theo, The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells, Adipocyte, 10, 1, 2021. Crossref

  159. Mposula Slindelo, Amoako Daniel G., Somboro Anou M., Arhin Isaiah, Kumalo Hezekiel M., Khan Rene B., Apoptosis-inducing effects of Terminalia phanerophlebia leaf extracts on human renal cells, South African Journal of Botany, 139, 2021. Crossref

  160. Mehta Rutika, Wood Anthony C, Yu James, Kim Richard, Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies, Expert Opinion on Investigational Drugs, 30, 4, 2021. Crossref

  161. Lin Hui, Peng Yizhong, Li Jinye, Wang Zhe, Chen Sheng, Qing Xiangcheng, Pu Feifei, Lei Ming, Shao Zengwu, Kozlov Andrey V., Reactive Oxygen Species Regulate Endoplasmic Reticulum Stress and ER-Mitochondrial Ca2+ Crosstalk to Promote Programmed Necrosis of Rat Nucleus Pulposus Cells under Compression, Oxidative Medicine and Cellular Longevity, 2021, 2021. Crossref

  162. Zhao Xiaoxia, Zhang Ning, Huang Yingying, Dou Xiaojing, Peng Xiaolin, Wang Wei, Zhang Zhe, Wang Ran, Qiu Yuling, Jin Meihua, Kong Dexin, Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref

  163. Wen Deng-tai, Zheng Lan, Lu Kai, Hou Wen-qi, Activation of cardiac Nmnat/NAD+/SIR2 pathways mediates endurance exercise resistance to lipotoxic cardiomyopathy in aging Drosophila , Journal of Experimental Biology, 224, 18, 2021. Crossref

  164. Hoong Caroline W S, Chua Marvin W J, SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases, Endocrinology, 162, 8, 2021. Crossref

  165. Caracciolo Daniele, Riillo Caterina, Di Martino Maria Teresa, Tagliaferri Pierosandro, Tassone Pierfrancesco, Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ Heel, Cancers, 13, 6, 2021. Crossref

  166. Gari Abdulrahim , Rawas Ghufran , Mufti Ahmad , Elemam Omima , BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients, International Journal Of Pharmaceutical Research And Allied Sciences, 10, 3, 2021. Crossref

  167. Blacker A. John, Moran-Malagon Gabriel, Powell Lyn, Reynolds William, Stones Rebecca, Chapman Michael R., Development of an SNAr Reaction: A Practical and Scalable Strategy To Sequester and Remove HF, Organic Process Research & Development, 22, 9, 2018. Crossref

  168. Gao Fei Fei, Quan Juan-Hua, Lee Min A., Ye Wei, Yuk Jae-Min, Cha Guang-Ho, Choi In-Wook, Lee Young-Ha, Trichomonas vaginalis induces apoptosis via ROS and ER stress response through ER–mitochondria crosstalk in SiHa cells, Parasites & Vectors, 14, 1, 2021. Crossref

  169. Radu Mihaela Raluca, Prădatu Alina, Duică Florentina, Micu Romeo, Creţoiu Sanda Maria, Suciu Nicolae, Creţoiu Dragoş, Varlas Valentin Nicolae, Rădoi Viorica Elena, Ovarian Cancer: Biomarkers and Targeted Therapy, Biomedicines, 9, 6, 2021. Crossref

  170. Paterniti Irene, Scuderi Sarah Adriana, Casili Giovanna, Lanza Marika, Mare Marzia, Giuffrida Raffella, Colarossi Cristina, Portelli Marco, Cuzzocrea Salvatore, Esposito Emanuela, Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma, Biomedicines, 9, 7, 2021. Crossref

  171. Villatoro Antonio J., Martín-Astorga María del Carmen, Alcoholado Cristina, Cárdenas Casimiro, Fariñas Fernando, Becerra José, Visser Rick, Altered Proteomic Profile of Adipose Tissue-Derived Mesenchymal Stem Cell Exosomes from Cats with Severe Chronic Gingivostomatitis, Animals, 11, 8, 2021. Crossref

  172. Wang Junwei, Li Hui, He Guangchao, Chu Zhaoxing, Peng Kewen, Ge Yiran, Zhu Qihua, Xu Yungen, Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy, Journal of Medicinal Chemistry, 63, 1, 2020. Crossref

  173. Marijon Hélène, Gery Sigal, Chang Hua, Landesman Yosef, Shacham Sharon, Lee Dhong Hyun, Gramont Aimery de, Koeffler Harold Phillip, Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status, Oncotarget, 12, 18, 2021. Crossref

  174. Nakamura-Bencomo Sayuri, Gutierrez Denisse A., Robles-Escajeda Elisa, Iglesias-Figueroa Blanca, Siqueiros-Cendón Tania S., Espinoza-Sánchez Edward A., Arévalo-Gallegos Sigifredo, Aguilera Renato J., Rascón-Cruz Quintín, Varela-Ramirez Armando, Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities, Investigational New Drugs, 39, 2, 2021. Crossref

  175. Yang Grace, Fontaine Danielle, Lodh Sukanya, Blumer Joseph, Roopra Avtar, Davis Dawn, TCF19 Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic β-Cell, Metabolites, 11, 8, 2021. Crossref

  176. Nakamoto Meagan Y., Rudolph Johannes, Wuttke Deborah S., Luger Karolin, Nonspecific Binding of RNA to PARP1 and PARP2 Does Not Lead to Catalytic Activation, Biochemistry, 58, 51, 2019. Crossref

  177. Rasool Fayyaz, Sharma Deepu, Anand P. Shanmukha, Magani SKJ, Tantravahi Srinivasan, Evaluation of the Anticancer Properties of Geranyl Isovalerate, an Active Ingredient of Argyreia nervosa Extract in Colorectal Cancer Cells, Frontiers in Pharmacology, 12, 2021. Crossref

  178. Szymaniak Brittany, Ross Ashley E., Morgans Alicia K., Genetics in prostate cancer: implications for clinical practice, Current Opinion in Supportive & Palliative Care, 15, 4, 2021. Crossref

  179. Andreidesz Kitti, Koszegi Balazs, Kovacs Dominika, Bagone Vantus Viola, Gallyas Ferenc, Kovacs Krisztina, Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells, International Journal of Molecular Sciences, 22, 4, 2021. Crossref

  180. Bianchi Anna Rita, Ferreri Carla, Ruggiero Simona, Deplano Simone, Sunda Valentina, Galloro Giuseppe, Formisano Cesare, Faraone Mennella Maria Rosaria, Automodification of PARP and fatty acid-based membrane lipidome as a promising integrated biomarker panel in molecular medicine, Biomarkers in Medicine, 10, 3, 2016. Crossref

  181. Mohammad Shokouhian , Shahidi Minoo, Gholampour Mohammad Ali, The Effect of miR-155 on DNA Damage in Mesenchymal Stem Cells, Cell and Tissue Biology, 14, 5, 2020. Crossref

  182. Gonzalez Rafael, Havrilesky Laura J., Myers Evan R., Secord Angeles Alvarez, Dottino Joseph A., Berchuck Andrew, Moss Haley A., Cost-effectiveness analysis comparing “PARP inhibitors-for-all” to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer, Gynecologic Oncology, 159, 2, 2020. Crossref

  183. Frascotti Gianni, Galbiati Elisabetta, Mazzucchelli Matteo, Pozzi Maria, Salvioni Lucia, Vertemara Jacopo, Tortora Paolo, The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy, Cancers, 13, 4, 2021. Crossref

  184. Kohan-Ghadr Hamid-Reza, Armistead Brooke, Berg Mikaela, Drewlo Sascha, Irisin Protects the Human Placenta from Oxidative Stress and Apoptosis via Activation of the Akt Signaling Pathway, International Journal of Molecular Sciences, 22, 20, 2021. Crossref

  185. Pan Yiming, Chen Lingyan, Li Ruibai, Liu Yu, Nan Mengdie, Hou Li, Kang Wen yi, Tanshinone IIa Induces Autophagy and Apoptosis via PI3K/Akt/mTOR Axis in Acute Promyelocytic Leukemia NB4 Cells, Evidence-Based Complementary and Alternative Medicine, 2021, 2021. Crossref

  186. Centko Ryan M., Carlile Graeme W., Barne Isabel, Patrick Brian O., Blagojevic Polina, Thomas David Y., Andersen Raymond J., Combination of Selective PARP3 and PARP16 Inhibitory Analogues of Latonduine A Corrects F508del-CFTR Trafficking, ACS Omega, 5, 40, 2020. Crossref

  187. Amina Musarat, Al Musayeib Nawal M., Alarfaj Nawal A., El-Tohamy Maha F., Al-Hamoud Gadah A., De Matteis Valeria , Antibacterial and Anticancer Potentials of Presynthesized Photosensitive Plectranthus cylindraceus Oil/TiO2/Polyethylene Glycol Polymeric Bionanocomposite, Bioinorganic Chemistry and Applications, 2021, 2021. Crossref

  188. Dallavalle Sabrina, Musso Loana, Artali Roberto, Aviñó Anna, Scaglioni Leonardo, Eritja Ramon, Gargallo Raimundo, Mazzini Stefania, G-quadruplex binding properties of a potent PARP-1 inhibitor derived from 7-azaindole-1-carboxamide, Scientific Reports, 11, 1, 2021. Crossref

  189. Matveev V. B., Khalmurzaev O. A., Evsyukova O. I., International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review, Cancer Urology, 16, 4, 2021. Crossref

  190. Wallace Sean R., Chihab Leila Y., Yamasaki Miles, Yoshinaga Braden T., Torres Yazmin M., Rideaux Damon, Javed Zeeshan, Turumella Soumya, Zhang Michelle, Lawton Dylan R., Fuller Amelia A., Carter-O’Connell Ian, Rapid Analysis of ADP-Ribosylation Dynamics and Site-Specificity Using TLC-MALDI, ACS Chemical Biology, 16, 11, 2021. Crossref

  191. Goutas Dimitrios, Goutas Nikolaos, Theocharis Stamatios, Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance, Cancers, 13, 18, 2021. Crossref

  192. Revathi Pagadala, Kanth Sivan Sree, Gururaj Somadi, Chander Origanti Subhash, Rajender Potlapally Sarita, Understanding structural characteristics of PARP-1 inhibitors through combined 3D-QSAR and molecular docking studies and discovery of new inhibitors by multistage virtual screening, Structural Chemistry, 32, 5, 2021. Crossref

  193. Kumar Sharma Ajay, Shaw Priyanka, Kalonia Aman, Yashavarddhan M.H., Chaudhary Pankaj, Vibhuti Arpana, Kumar Shukla Sandeep, Recent Perspectives in Radiation-Mediated DNA Damage and Repair: Role of NHEJ and Alternative Pathways, in DNA - Damages and Repair Mechanisms, 2021. Crossref

  194. Boo Yong Chool, Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation, Antioxidants, 10, 8, 2021. Crossref

  195. Kontandreopoulou Christina-Nefeli, Diamantopoulos Panagiotis T., Tiblalexi Despina, Giannakopoulou Nefeli, Viniou Nora-Athina, PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome, Blood Advances, 5, 22, 2021. Crossref

  196. Koosha Fereshteh, Eynali Samira, Eyvazzadeh Nazila, Kamalabadi Mahdieh Ahmadi, The effect of iodine-131 beta-particles in combination with A-966492 and Topotecan on radio-sensitization of glioblastoma: An in-vitro study, Applied Radiation and Isotopes, 177, 2021. Crossref

  197. Al-Mugotir Mona, Lovelace Jeffrey J., George Joseph, Bessho Mika, Pal Dhananjaya, Struble Lucas, Kolar Carol, Rana Sandeep, Natarajan Amarnath, Bessho Tadayoshi, Borgstahl Gloria E. O., Galli Alvaro, Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction, PLOS ONE, 16, 3, 2021. Crossref

  198. Mannan Ashi, Garg Nikhil, Singh Thakur Gurjeet, Kang Harmeet Kaur, Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury, Neurochemical Research, 46, 11, 2021. Crossref

  199. Rashidbaghan Azam, Mostafaie Ali, Yazdani Yaghoub, Mansouri Kamran, The Agglutinin of Common Nettle (Urtica dioica L.) Plant Effects on Gene Expression Related to Apoptosis of Human Acute Myeloid Leukemia Cell Line, Biochemical Genetics, 59, 4, 2021. Crossref

  200. Korotchkina Lioubov, Kazyulkin Denis, Komarov Pavel G., Polinsky Alex, Andrianova Ekaterina L., Joshi Sangeeta, Gupta Mahima, Vujcic Slavoljub, Kononov Eugene, Toshkov Ilia, Tian Yuan, Krasnov Peter, Chernov Mikhail V., Veith Jean, Antoch Marina P., Middlemiss Shiloh, Somers Klaartje, Lock Richard B., Norris Murray D., Henderson Michelle J., Haber Michelle, Chernova Olga B., Gudkov Andrei V., OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis, Leukemia, 34, 7, 2020. Crossref

  201. Rizvi Asim, Merlin Marine A., Shah Girish M., Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: Potential impact in cancer stem cells and therapeutic implications, European Journal of Pharmacology, 911, 2021. Crossref

  202. Manska Salomé, Rossetto Cyprian C., Identification of cellular proteins associated with human cytomegalovirus (HCMV) DNA replication suggests novel cellular and viral interactions, Virology, 566, 2022. Crossref

  203. Gentilin Erica, Cani Alice, Simoni Edi, Chicca Milvia, Di Paolo Maria Luisa, Martini Alessandro, Astolfi Laura, Hydrogen peroxide toxicity on auditory cells: An in vitro study, Chemico-Biological Interactions, 345, 2021. Crossref

  204. Marilovtseva E. V., Studitsky V. M., Guanine Quadruplexes in Cell Nucleus Metabolism, Molecular Biology, 55, 5, 2021. Crossref

  205. Zhao Jian, Li Hewei, Li Wanying, Wang Zixian, Dong Zhewen, Lan Huan, Wang Chengqiang, Song Jia-Le, M. da Silva Lu sa, Effects of Sinapic Acid Combined with Cisplatin on the Apoptosis and Autophagy of the Hepatoma Cells HepG2 and SMMC-7721, Evidence-Based Complementary and Alternative Medicine, 2021, 2021. Crossref

  206. Valabrega Giorgio, Scotto Giulia, Tuninetti Valentina, Pani Arianna, Scaglione Francesco, Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy, International Journal of Molecular Sciences, 22, 8, 2021. Crossref

  207. Anderson Mark G., Zhang Qian, Rodriguez Luis E., Hecquet Claudie M., Donawho Cherrie K., Ansell Peter J., Reilly Edward B., ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition, BMC Cancer, 21, 1, 2021. Crossref

  208. Mani Chinnadurai, Tripathi Kaushlendra, Chaudhary Sandeep, Somasagara Ranganatha R., Rocconi Rodney P., Crasto Chiquito, Reedy Mark, Athar Mohammad, Palle Komaraiah, Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition., Neoplasia, 23, 9, 2021. Crossref

  209. Alugoju Phaniendra, Chaitanya Nyshadham S.N., Krishna Swamy V.K.D., Kancharla Pavan Kumar, Phytotherapy for breast cancer, in A Theranostic and Precision Medicine Approach for Female-Specific Cancers, 2021. Crossref

  210. Sorolla Maria Alba, Hidalgo Ivan, Sorolla Anabel, Montal Robert, Pallisé Ona, Salud Antonieta, Parisi Eva, Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities, Cancers, 13, 20, 2021. Crossref

  211. Cherng Yih-Giun, Chu Yi Cheng, Yadav Vijesh Kumar, Huang Ting-Yi, Hsieh Ming-Shou, Lee Kwai-Fong, Lee Wei-Hwa, Yeh Chi-Tai, Ong Jiann Ruey, Induced Mitochondrial Alteration and DNA Damage via IFNGR-JAK2-STAT1-PARP1 Pathway Facilitates Viral Hepatitis Associated Hepatocellular Carcinoma Aggressiveness and Stemness, Cancers, 13, 11, 2021. Crossref

  212. Chin Sang Christopher, Moore Gaelen, Lee Hyun O., Concepts | No Membrane, No Problem: Cellular Organization by Biomolecular Condensates, in Encyclopedia of Biological Chemistry III, 2021. Crossref

  213. Colombo Giorgia, Gelardi Edoardo Luigi Maria, Balestrero Federica Carolina, Moro Marianna, Travelli Cristina, Genazzani Armando A., Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer, Frontiers in Pharmacology, 12, 2021. Crossref

  214. Wang Ying-Qing, Wang Ping-Yuan, Wang Yu-Ting, Yang Guang-Fu, Zhang Ao, Miao Ze-Hong, An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy, Journal of Medicinal Chemistry, 59, 21, 2016. Crossref

  215. Braune Steffen, Krüger-Genge Anne, Kammerer Sarah, Jung Friedrich, Küpper Jan-Heiner, Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies, Life, 11, 2, 2021. Crossref

  216. Haider Mohamed, Elsherbeny Amr, Pittalà Valeria, Fallica Antonino N., Alghamdi Maha Ali, Greish Khaled, The Potential Role of Sildenafil in Cancer Management through EPR Augmentation, Journal of Personalized Medicine, 11, 6, 2021. Crossref

  217. Patel Parasvi S., Algouneh Arash, Hakem Razq, Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand, Oncogene, 40, 17, 2021. Crossref

  218. Arruri Vijay Kumar, Gundu Chayanika, Khan Islauddin, Khatri Dharmendra Kumar, Singh Shashi Bala, PARP overactivation in neurological disorders, Molecular Biology Reports, 48, 3, 2021. Crossref

  219. Kim Dae-Seok, Challa Sridevi, Jones Aarin, Kraus W. Lee, PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis, Genes & Development, 34, 5-6, 2020. Crossref

  220. Myers Samuel H., Ortega Jose Antonio, Cavalli Andrea, Synthetic Lethality through the Lens of Medicinal Chemistry, Journal of Medicinal Chemistry, 63, 23, 2020. Crossref

  221. Liu Jinsha, Pandya Priyanka, Afshar Sepideh, Therapeutic Advances in Oncology, International Journal of Molecular Sciences, 22, 4, 2021. Crossref

  222. Farghadani Reyhaneh, Naidu Rakesh, Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer, Cancers, 13, 14, 2021. Crossref

  223. Boughey Harvey, Jurga Mateusz, El-Khamisy Sherif F., DNA Homeostasis and Senescence: Lessons from the Naked Mole Rat, International Journal of Molecular Sciences, 22, 11, 2021. Crossref

  224. Neiger Hannah E., Siegler Emily L., Shi Yihui, Breast Cancer Predisposition Genes and Synthetic Lethality, International Journal of Molecular Sciences, 22, 11, 2021. Crossref

  225. Wang Hexiang, Ren Bo, Liu Ye, Jiang Beibei, Guo Yin, Wei Min, Luo Lusong, Kuang Xianzhao, Qiu Ming, Lv Lei, Xu Hong, Qi Ruipeng, Yan Huibin, Xu Dexu, Wang Zhiwei, Huo Chang-Xin, Zhu Yutong, Zhao Yuan, Wu Yiyuan, Qin Zhen, Su Dan, Tang Tristin, Wang Fan, Sun Xuebing, Feng Yingcai, Peng Hao, Wang Xing, Gao Yajuan, Liu Yong, Gong Wenfeng, Yu Fenglong, Liu Xuesong, Wang Lai, Zhou Changyou, Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development, Journal of Medicinal Chemistry, 63, 24, 2020. Crossref

  226. Mayfield Andrew B., Metternich Jan B., Trotta Adam H., Jacobsen Eric N., Stereospecific Furanosylations Catalyzed by Bis-thiourea Hydrogen-Bond Donors, Journal of the American Chemical Society, 142, 8, 2020. Crossref

  227. Eleazer Rebekah, Fondufe‐Mittendorf Yvonne N., The multifaceted role of PARP1 in RNA biogenesis , WIREs RNA, 12, 2, 2021. Crossref

  228. Gergues Marina, Savanur Vibha Harindra, Prado David, Eljarrah Adam, Liu James K., Jaloudi Mohammed, Rameshwar Pranela, Therapeutic approaches to overcome temozolomide resistance in glioblastoma, in Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies, 2021. Crossref

  229. Rudolph Johannes, Mahadevan Jyothi, Luger Karolin, Probing the Conformational Changes Associated with DNA Binding to PARP1, Biochemistry, 59, 21, 2020. Crossref

  230. Rudolph Johannes, Roberts Genevieve, Muthurajan Uma M, Luger Karolin, HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase, eLife, 10, 2021. Crossref

  231. Fathy Rasha M., Mahfouz Amira Yahia, Eco-friendly graphene oxide-based magnesium oxide nanocomposite synthesis using fungal fermented by-products and gamma rays for outstanding antimicrobial, antioxidant, and anticancer activities, Journal of Nanostructure in Chemistry, 11, 2, 2021. Crossref

  232. Sloan Gordon, Selvarajah Dinesh, Tesfaye Solomon, Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy, Nature Reviews Endocrinology, 17, 7, 2021. Crossref

  233. Wang Yudi, Chen Jiawen, Liang Xiao, Han Haobo, Wang Hao, Yang Yan, Li Quanshun, An ATP-Responsive Codelivery System of Doxorubicin and MiR-34a To Synergistically Inhibit Cell Proliferation and Migration, Molecular Pharmaceutics, 14, 7, 2017. Crossref

  234. Thepthanee Chorpaka, Liu Chan-Chiung, Yu Hsu-Sheng, Huang Ho-Shin, Yen Chia-Hung, Li Yen-Hsien, Lee Maw-Rong, Liaw Ean-Tun, Evaluation of Phytochemical Contents and In Vitro Antioxidant, Anti-Inflammatory, and Anticancer Activities of Black Rice Leaf (Oryza sativa L.) Extract and Its Fractions, Foods, 10, 12, 2021. Crossref

  235. Zimmer Kai, Kocher Florian, Puccini Alberto, Seeber Andreas, Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives, Frontiers in Oncology, 11, 2021. Crossref

  236. Rudolph Johannes, Roberts Genevieve, Luger Karolin, Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs, Nature Communications, 12, 1, 2021. Crossref

  237. Siani Paulo, Di Valentin Cristiana, Effect of dopamine-functionalization, charge and pH on protein corona formation around TiO2 nanoparticles, Nanoscale, 14, 13, 2022. Crossref

  238. Yan Jie, Chen Yiyi, Zhu Yu, Paquet-Durand François, Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?, International Journal of Molecular Sciences, 22, 19, 2021. Crossref

  239. Malyarenko Olesya S., Usoltseva Roza V., Silchenko Artem S., Ermakova Svetlana P., Aminated laminaran from brown alga Saccharina cichorioides: Synthesis, structure, anticancer, and radiosensitizing potential in vitro, Carbohydrate Polymers, 250, 2020. Crossref

  240. Nguyen Joe Truong, Haidar Fatima Sarah, Fox Alexandra Lucienne, Ray Connor, Mendonça Daniela Baccelli, Kim Jin Koo, Krebsbach Paul H., mEAK-7 Forms an Alternative mTOR Complex with DNA-PKcs in Human Cancer, iScience, 17, 2019. Crossref

  241. Mekonnen Negesse, Yang Hobin, Shin Young Kee, Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors, Frontiers in Oncology, 12, 2022. Crossref

  242. Hughes Camilla H K, Mezera Megan A, Wiltbank Milo C, Pate Joy L, Insights from two independent transcriptomic studies of the bovine corpus luteum during pregnancy, Journal of Animal Science, 100, 7, 2022. Crossref

  243. Wang Xiaoqing, Li Fei, Liu Jialin, Li Qiongyu, Ji Chenglong, Wu Huifeng, New insights into the mechanism of hepatocyte apoptosis induced by typical organophosphate ester: An integrated in vitro and in silico approach, Ecotoxicology and Environmental Safety, 219, 2021. Crossref

  244. McSwain Leon F., Parwani Kiran K., Shahab Shubin W., Hambardzumyan Dolores, MacDonald Tobey J., Spangle Jennifer M., Kenney Anna Marie, Medulloblastoma and the DNA Damage Response, Frontiers in Oncology, 12, 2022. Crossref

  245. Joung Jae Young, Kim Sung Han, The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer, The Korean Journal of Urological Oncology, 20, 1, 2022. Crossref

  246. Wolf Christopher, Smith Sonja, van Wijk Sjoerd J. L., Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells, International Journal of Molecular Sciences, 23, 7, 2022. Crossref

  247. Gutierrez Denisse A., Contreras Lisett, Villanueva Paulina J., Borrego Edgar A., Morán-Santibañez Karla, Hess Jessica D., DeJesus Rebecca, Larragoity Manuel, Betancourt Ana P., Mohl Jonathon E., Robles-Escajeda Elisa, Begum Khodeza, Roy Sourav, Kirken Robert A., Varela-Ramirez Armando, Aguilera Renato J., Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways, Cells, 11, 2, 2022. Crossref

  248. Hanna Daire, Chopra Neha, Hochhauser Daniel, Khan Khurum, The role of PARP inhibitors in gastrointestinal cancers, Critical Reviews in Oncology/Hematology, 171, 2022. Crossref

  249. Khashkhashi Moghadam Sattar, Bakhshinejad Babak, Khalafizadeh Ali, Mahmud Hussen Bashdar, Babashah Sadegh, Non‐coding RNA‐associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma, Journal of Cellular and Molecular Medicine, 26, 2, 2022. Crossref

  250. Palminha Nelma M., Hashish Sara Ahmed, Rabie Eman, Saber Sherine Khalafalla, Nutrigenomics of Aging, in Nutrigenomics and the Brain, 2022. Crossref

  251. Nakamura Kohei, Aimono Eriko, Tanishima Shigeki, Imai Mitsuho, Nagatsuma Akiko Kawano, Hayashi Hideyuki, Yoshimura Yuki, Nakayama Kentaro, Kyo Satoru, Nishihara Hiroshi, Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer, JCO Precision Oncology, 4, 2020. Crossref

  252. Johnson Sarah, Karpova Yaroslava, Guo Danping, Ghatak Atreyi, Markov Dmitriy A., Tulin Alexei V., PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment, BMC Cancer, 22, 1, 2022. Crossref

  253. Tarsounas Madalena, Sung Patrick, The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication, Nature Reviews Molecular Cell Biology, 21, 5, 2020. Crossref

  254. Nie Yunjuan, Nirujogi Teja Srinivas, Ranjan Ravi, Reader Brenda F., Chung Sangwoon, Ballinger Megan N., Englert Joshua A., Christman John W., Karpurapu Manjula, PolyADP-Ribosylation of NFATc3 and NF-κB Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury, Journal of Innate Immunity, 13, 2, 2021. Crossref

  255. De Mello Ramon Andrade, Castelo-Branco Luis, Castelo-Branco Pedro, Pozza Daniel Humberto, Vermeulen Louis, Palacio Sofia, Salzberg Matthew, Lockhart A. Craig, What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?, American Society of Clinical Oncology Educational Book, 38, 2018. Crossref

  256. Siebert Aisha L., Szymaniak Brittany M., Numan Yazan, Morgans Alicia K., Genetically Informed Prostate Cancer Treatment for Metastatic Disease, Urologic Clinics of North America, 48, 3, 2021. Crossref

  257. Takahashi Naoki, Iguchi Tomoki, Kuroda Minpei, Mishima Masaki, Mimaki Yoshihiro, Novel Oleanane-Type Triterpene Glycosides from the Saponaria officinalis L. Seeds and Apoptosis-Inducing Activity via Mitochondria, International Journal of Molecular Sciences, 23, 4, 2022. Crossref

  258. Vishwanath Divakar, Girimanchanaika Swamy S., Dukanya Dukanya, Rangappa Shobith, Yang Ji-Rui, Pandey Vijay, Lobie Peter E., Basappa Basappa, Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase, Molecules, 27, 3, 2022. Crossref

  259. Shah Shreya M., Demidova Elena V., Lesh Randy W., Hall Michael J., Daly Mary B., Meyer Joshua E., Edelman Martin J., Arora Sanjeevani, Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology, Cancer Treatment Reviews, 104, 2022. Crossref

  260. Haber Alex O., Jain Aditi, Mani Chinnadurai, Nevler Avinoam, Agostini Lebaron C., Golan Talia, Palle Komaraiah, Yeo Charles J., Gmeiner William H., Brody Jonathan R., AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhibition, Molecular Cancer Research, 19, 4, 2021. Crossref

  261. Adamus-Grabicka Angelika A., Daśko Mateusz, Hikisz Pawel, Kusz Joachim, Malecka Magdalena, Budzisz Elzbieta, Biochemical, Structural Analysis, and Docking Studies of Spiropyrazoline Derivatives, International Journal of Molecular Sciences, 23, 11, 2022. Crossref

  262. Sochacka-Ćwikła Aleksandra, Mączyński Marcin, Regiec Andrzej, FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021, Molecules, 27, 7, 2022. Crossref

  263. Richard Iain A., Burgess Joshua T., O’Byrne Kenneth J., Bolderson Emma, Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics, Frontiers in Cell and Developmental Biology, 9, 2022. Crossref

  264. Cai Zhaolun, Liu Chunyu, Chang Chen, Shen Chaoyong, Yin Yuan, Yin Xiaonan, Jiang Zhiyuan, Zhao Zhou, Mu Mingchun, Cao Dan, Zhang Lingli, Zhang Bo, Comparative safety and tolerability of approved PARP inhibitors in cancer: A systematic review and network meta-analysis, Pharmacological Research, 172, 2021. Crossref

  265. Yan Jie, Günter Alexander, Das Soumyaparna, Mühlfriedel Regine, Michalakis Stylianos, Jiao Kangwei, Seeliger Mathias W., Paquet-Durand François, Inherited Retinal Degeneration: PARP-Dependent Activation of Calpain Requires CNG Channel Activity, Biomolecules, 12, 3, 2022. Crossref

  266. Rodríguez Stewart Roxana M., Raghuram Vishnu, Berry Jameson T. L., Joshi Gaurav N., Mainou Bernardo A., Dutch Rebecca Ellis, Noncanonical Cell Death Induction by Reassortant Reovirus, Journal of Virology, 94, 22, 2020. Crossref

  267. Stotz Sophie, Kinzler Johannes, Nies Anne T., Schwab Matthias, Maurer Andreas, Two experts and a newbie: [18F]PARPi vs [18F]FTT vs [18F]FPyPARP—a comparison of PARP imaging agents, European Journal of Nuclear Medicine and Molecular Imaging, 49, 3, 2022. Crossref

  268. Kumar Vikas, Kumar Anurag, Mir Khursheed Ul Islam, Yadav Vandana, Chauhan Shyam Singh, Pleiotropic role of PARP1: an overview, 3 Biotech, 12, 1, 2022. Crossref

  269. Hopkins Todd A., Shi Yan, Rodriguez Luis E., Solomon Larry R., Donawho Cherrie K., DiGiammarino Enrico L., Panchal Sanjay C., Wilsbacher Julie L., Gao Wenqing, Olson Amanda M., Stolarik DeAnne F., Osterling Donald J., Johnson Eric F., Maag David, Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors, Molecular Cancer Research, 13, 11, 2015. Crossref

  270. Ling Xiaoxuan, Pan Zhijie, Zhang Haiqiao, Wu Minhua, Gui Zhiming, Yuan Qian, Chen Jialong, Peng Jianming, Liu Zhidong, Tan Qiang, Huang Dongsheng, Xiu Liangchang, Liu Linhua, PARP‐1 modulates the expression of miR‐223 through histone acetylation to involve in the hydroquinone‐induced carcinogenesis of TK6 cells, Journal of Biochemical and Molecular Toxicology, 36, 9, 2022. Crossref

  271. Xu Zhen, Vandenberg Cassandra J., Lieschke Elizabeth, Di Rago Ladina, Scott Clare L., Majewski Ian J., CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors, Molecular Cancer Research, 19, 8, 2021. Crossref

  272. Lau Tsz-Ying, Kwan Hiu-Yee, Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer, Marine Drugs, 20, 6, 2022. Crossref

  273. Elbæk Camilla R., Petrosius Valdemaras, Sørensen Claus S., WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 819-820, 2020. Crossref

  274. Tang Liujiu, Bao Shuyin, Du Yu, Jiang Zengyan, Wuliji AO, Ren Xiang, Zhang Chenghong, Chu Haiying, Kong Li, Ma Haiying, Antioxidant effects of Lycium barbarum polysaccharides on photoreceptor degeneration in the light-exposed mouse retina, Biomedicine & Pharmacotherapy, 103, 2018. Crossref

  275. Anjaly Km, Tiku Ashu Bhan, Caffeic acid phenethyl ester induces radiosensitization via inhibition of DNA damage repair in androgen‐independent prostate cancer cells , Environmental Toxicology, 37, 5, 2022. Crossref

  276. Lakshmanan Kaviarasan, Hemanth Kantabathina, Krishnamurthy Praveen T., Rajagopal Kalirajan, Byran Gowramma, Design, Synthesis, and In-Vitro Biological Evaluation of PARP-1 Inhibitors Based on a 4-(Benzylideneamino)-N-(Quinolin-8-yl)Benzamide Scaffold, Polycyclic Aromatic Compounds, 2022. Crossref

  277. Cimmino Luisa, Dolgalev Igor, Wang Yubao, Yoshimi Akihide, Martin Gaëlle H., Wang Jingjing, Ng Victor, Xia Bo, Witkowski Matthew T., Mitchell-Flack Marisa, Grillo Isabella, Bakogianni Sofia, Ndiaye-Lobry Delphine, Martín Miguel Torres, Guillamot Maria, Banh Robert S., Xu Mingjiang, Figueroa Maria E., Dickins Ross A., Abdel-Wahab Omar, Park Christopher Y., Tsirigos Aristotelis, Neel Benjamin G., Aifantis Iannis, Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression, Cell, 170, 6, 2017. Crossref

  278. Ramakrishnan Muthusamy, Papolu Pradeep K., Satish Lakkakula, Vinod Kunnummal Kurungara, Wei Qiang, Sharma Anket, Emamverdian Abolghassem, Zou Long-Hai, Zhou Mingbing, Redox status of the plant cell determines epigenetic modifications under abiotic stress conditions and during developmental processes, Journal of Advanced Research, 2022. Crossref

  279. Bhattacharjee Sayani, Sullivan Matthew J., Wynn Rebecca R., Demagall Alex, Hendrix Andrew S., Sindhwani Puneet, Petros Firas G., Nadiminty Nagalakshmi, PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth, BMC Cancer, 22, 1, 2022. Crossref

  280. Tayarani-Najaran Zahra, Hadipour Elham, Seyed Mousavi Seyed Mahdi, Emami Seyed Ahmad, Mohtashami Leila, Javadi Behjat, Protective effects of Lavandula stoechas L. methanol extract against 6-OHDA-induced apoptosis in PC12 cells, Journal of Ethnopharmacology, 273, 2021. Crossref

  281. Al Hroob Amir M., Abukhalil Mohammad H., Hussein Omnia E., Mahmoud Ayman M., Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate, Biomedicine & Pharmacotherapy, 109, 2019. Crossref

  282. Sigorski Dawid, Iżycka-Świeszewska Ewa, Bodnar Lubomir, Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data, Targeted Oncology, 15, 6, 2020. Crossref

  283. Chandrasekaran Akshaya, Elias Kevin M., Synthetic Lethality in Ovarian Cancer, Molecular Cancer Therapeutics, 20, 11, 2021. Crossref

  284. Tiwari Palak, Khan Heena, Singh Thakur Gurjeet, Grewal Amarjot Kaur, Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke, Neurochemical Research, 47, 7, 2022. Crossref

  285. Maigali Soher S., El‐Shanawany Hala R., El‐Sayed Naglaa F., Youssef Mohamed A., Fouad Marwa A., Synthesis and evaluation of a new series of spiro aryl dioxolane compounds: A new scaffold as potential poly(ADP‐ribose)polymerase‐1 ( PARP ‐1) inhibitors , Journal of Heterocyclic Chemistry, 2022. Crossref

  286. Dellomo Anna J., Abbotts Rachel, Eberly Christian L., Karbowski Mariusz, Baer Maria R., Kingsbury Tami J., Rassool Feyruz V., PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers, Translational Oncology, 15, 1, 2022. Crossref

  287. Zhu Yu, Cao Bowen, Tolone Arianna, Yan Jie, Christensen Gustav, Arango-Gonzalez Blanca, Ueffing Marius, Paquet-Durand François, In vitro Model Systems for Studies Into Retinal Neuroprotection, Frontiers in Neuroscience, 16, 2022. Crossref

  288. Akpolat Meryem, Oz Zehra Safi, Gulle Kanat, Hamamcioglu Ayse C., Bakkal Bekir H., Kececi Mete, X irradiation induced colonic mucosal injury and the detection of apoptosis through PARP-1/p53 regulatory pathway, Biomedicine & Pharmacotherapy, 127, 2020. Crossref

  289. Ramos-Solis Nicole, Yeh Elizabeth S., Triple Negative Breast Cancer, in Comprehensive Pharmacology, 2022. Crossref

  290. Bisht Priya, Kumar V. Udaya, Pandey Ruchi, Velayutham Ravichandiran, Kumar Nitesh, Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development, Frontiers in Pharmacology, 13, 2022. Crossref

  291. Jiang Jun, Bao Xun, Yue Yang, Schiff David, Bindra Ranjit, Li Jing, Development and validation of a liquid chromatography coupled with tandem mass spectrometry method for determining total and unbound pamiparib in human plasma and brain tumors, Biomedical Chromatography, 2022. Crossref

  292. Blum Joanne L., Laird A. Douglas, Litton Jennifer K., Rugo Hope S., Ettl Johannes, Hurvitz Sara A., Martin Miguel, Roché Henri H., Lee Kyung-Hun, Goodwin Annabel, Chen Ying, Lanzalone Silvana, Chelliserry Jijumon, Czibere Akos, Hopkins Julia F., Albacker Lee A., Mina Lida A., Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer, Clinical Cancer Research, 28, 7, 2022. Crossref

  293. Mark Paul R., NAD + deficiency in human congenital malformations and miscarriage: A new model of pleiotropy , American Journal of Medical Genetics Part A, 188, 9, 2022. Crossref

  294. Mazzini Stefania, Princiotto Salvatore, Artali Roberto, Musso Loana, Aviñó Anna, Eritja Ramon, Gargallo Raimundo, Dallavalle Sabrina, Exploring the Interaction of G-quadruplex Binders with a (3 + 1) Hybrid G-quadruplex Forming Sequence within the PARP1 Gene Promoter Region, Molecules, 27, 15, 2022. Crossref

  295. Li Lulu, Kumar Alagamuthu Karthick, Hu Zhigang, Guo Zhigang, Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy, Current Medicinal Chemistry, 28, 5, 2021. Crossref

  296. Kumar Sanjay, Verma Akanksha, Yadav Pardeep, Dubey Sumit Kumar, Azhar Esam Ibraheem, Maitra S. S., Dwivedi Vivek Dhar, Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies, Archives of Virology, 167, 9, 2022. Crossref

  297. Kirschning Andreas, On the evolution of coenzyme biosynthesis, Natural Product Reports, 2022. Crossref

  298. Rosario Roseanne, Cui Wanyuan, Anderson Richard A, Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies, Reproduction and Fertility, 3, 3, 2022. Crossref

  299. Even Caroline, Delord Jean-Pierre, Price Katharine A., Nakagawa Kazuhiko, Oh Do-Youn, Burge Matthew, Chung Hyun C., Doi Toshihiko, Fakih Marwan, Takahashi Shunji, Yao Lili, Jin Fan, Norwood Kevin, Hansen Aaron R., Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study, European Journal of Cancer, 171, 2022. Crossref

  300. Wu Jianjian, Wang Dejuan, Zhou Jiuyao, Li Juntao, Xie Ruoxin, Li Yiyuan, Huang Jiayu, Liu Bihao, Qiu Jianguang, Gambogenic acid induces apoptosis and autophagy through ROS ‐mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells , Phytotherapy Research, 2022. Crossref

  301. Raj Pulla Prudvi, Lakshmanan Kaviarasan, Byran Gowramma, Rajagopal Kalirajan, Krishnamurthy Praveen Thaggikuppe, Palati Divya Jyothi, Recent PARP Inhibitor Advancements in Cancer Therapy: A Review, Current Enzyme Inhibition, 18, 2, 2022. Crossref

  302. Clarke Thomas L., Mostoslavsky Raul, DNA repair as a shared hallmark in cancer and ageing, Molecular Oncology, 16, 18, 2022. Crossref

  303. Han So-Hee, Lee Jae-Han, Woo Joong-Seok, Jung Gi-Hwan, Jung Soo-Hyun, Han Eun-Ji, Kim Bumseok, Cho Sung Dae, Nam Jeong Seok, Che Jeong Hwan, Jung Ji-Youn, Myricetin induces apoptosis and autophagy in human gastric cancer cells through inhibition of the PI3K/Akt/mTOR pathway, Heliyon, 8, 5, 2022. Crossref

  304. Pham Wellington, Construction of Molecular Probes and Imaging Applications, in Principles of Molecular Probe Design and Applications, 2023. Crossref

  305. Khanahmad Hossein, Mirbod Seyedeh Mahnaz, karimi Farzaneh, Kharazinejad Ebrahim, Owjfard Maryam, Najaflu Malihe, Tavangar Mehrsa, Pathological Mechanisms Induced by TRPM2 Ion Channels Activation in Renal Ischemia-Reperfusion Injury, Molecular Biology Reports, 2022. Crossref

  306. Gedminas Jenna M, Laetsch Theodore W, Targeting the DNA damage response in pediatric malignancies, Expert Review of Anticancer Therapy, 22, 10, 2022. Crossref

  307. Ettl Tobias, Grube Matthias, Schulz Daniela, Bauer Richard Josef, Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers, Cancers, 14, 20, 2022. Crossref

  308. Carlsen Lindsey, El-Deiry Wafik S., Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation, Frontiers in Oncology, 12, 2022. Crossref

  309. Chalmeh A., Therapeutic regimens of endotoxaemia in sheep, BULGARIAN JOURNAL OF VETERINARY MEDICINE, 25, 4, 2022. Crossref

  310. Sabet Ziba, Vagiannis Dimitrios, Budagaga Youssif, Zhang Yu, Novotná Eva, Hanke Ivo, Rozkoš Tomáš, Hofman Jakub, Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study, International Journal of Molecular Sciences, 23, 22, 2022. Crossref

  311. Badawy Abdulla A.-B., Tryptophan metabolism and disposition in cancer biology and immunotherapy, Bioscience Reports, 42, 11, 2022. Crossref

  312. Tong Jie, Chen Baosheng, Tan Peng Wen, Kurpiewski Stephen, Cai Zhengxin, Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases, Frontiers in Medicine, 9, 2022. Crossref

将发表的论文

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain